# 2026 Wk 15 Impact Report

Under the continuous annual sequence, Week 15 covers April 5 through April 11, 2026. I found 68 emails, 7 meetings, 846 file or externally indexed results, and 1 directory result. I excluded automated announcements, broad newsletters, personal matters, unrelated enterprise reports, and records outside the Week 15 date range.

Weekly Impact Report

Week 15: April 5 through April 11, 2026

1. Executive Summary

Launched a focused Ultrasound benefit-risk analysis proof of concept using the existing XITE and Sutra foundation. The working team identified lifecycle sources spanning Windchill artifacts, complaints, Vertica logs, medical literature, standards, and an FDA benefit-risk template. The intended output is a connected, AI-assisted draft for expert review. [RE: AWS AI...k analysis | Outlook], [AWS AI POC...s example) | Meeting]

Established the benefit-risk POC as a potential extension of the completed XITE V&V work. The proposal described using the existing traceability foundation to connect clinical intent, design, verification evidence, observed anomalies, and benefit-risk justification. [Extension...k Analysis | Outlook]

Received concrete instructions for accessing Ultrasound log data. Brown, Cynthia provided the request paths for Ultrasound log access and database access, together with a location for Vertica-client training material. [RE: AWS AI...k analysis | Outlook]

Was asked to co-lead the cross-IEN roadmap for AI-assisted requirements and end-to-end traceability. Wartena, Frank asked Eldracher, Erik and me to bring together stakeholders across Quality and Reliability Engineering, Software Engineering, IEN Quality and Regulatory, and Patient Safety and Quality. [RE: Bringi...aceability | Outlook]

Received access to evaluate NOVA, an additional AI-assisted requirements tool. The tool analyzes selected requirement text against INCOSE rules, proposes an improved statement, and checks for similar requirements in the document. [NOVA for R...e- AI tool | Outlook]

Advanced IGT-D onboarding to Sutra through an explicitly bounded POC. The agreed assumptions limited ingestion to IntraSight URS, PRS, ERS, and test cases, with four specified traceability paths and remediation deferred until after the POC. [Alignment...pectations | Meeting]

Prepared the XITE Cohort Special Edition closeout contribution. I submitted the project-closing slides, and Stuijt, Tes confirmed that the slides were added to the closeout presentation. [Re: XITE C...ut session | Outlook]

Advanced preparation for both Innovation Impact Week sessions. Communications support was assigned for my April 20 deep dive, while the April 23 Inside XITE session received a shared presentation draft, a reserved hybrid room, and confirmation of the room’s Teams, camera, screen, and microphone setup. [RE: Prepar...deep Dive | Outlook], [Re: Import...ve session | Outlook], [Wirjosemit...a message | Outlook], [Wirjosemit..." with you | Outlook]

Raised an information-sharing question before providing XITE project outputs to an external PPP vendor. A discussion was arranged with Kleef, Ciska van to obtain guidance because the potential deliverables could be shared beyond Philips. [RE: Questi...PPP vendor | Outlook]

Continued the AIOrchestration pilot access effort. The team followed up for the HSP AWS account and service access needed for document ingestion, but the retrieved sources do not confirm that access was completed during Week 15. [RE: Implem...as a pilot | Outlook]

Supported Software Excellence recruiting and technical enablement. I accepted a proposed second-round DevOps interview slot, although the other interviewer could not attend, and I was referenced in work concerning DevOps Scrum Master and Premium Custom Runners adoption. [Re: 2nd Ro...24; 554023 | Outlook], [Mentioned...tion.loop" | Outlook]

2. Major Outcomes and Impact

Ultrasound benefit-risk analysis POC initiated

The AWS AI POC for Benefit risk analysis (Use X5-1C Xducer Noise as example) was scheduled on April 6 to explore using an existing XITE capability for an Ultrasound benefit-risk initiative. The meeting invitation described a goal of using AI with an AWS backend to generate an output that could support issue scoring, IIAs, HHE, and C&R decisions. [AWS AI POC...s example) | Meeting], [RE: AWS AI...k analysis | Outlook]

The follow-up identified a Flash-related example as a candidate starting point and listed the required information sources:

Flash SRS from Windchill;

Flash risk-management materials;

the applicable IFU;

medical literature;

standards and compliance documents;

complaint information;

Vertica-based system logs;

the FDA benefit-risk output template. [RE: AWS AI...k analysis | Outlook]

The intended approach is to connect the required nodes and assess whether the AI platform can produce a draft output for review. The correspondence explicitly emphasizes close work with Information and Security partners and a human-in-the-loop model. [RE: AWS AI...k analysis | Outlook]

The agreed follow-up items included:

obtain a blank FDA template and expectations for each section;

create a group chat for progress sharing;

create a SharePoint location for the data;

arrange walkthroughs so that the Sutra team understands the source information;

consider temperature rise as a second POC after the initial example. [RE: AWS AI...k analysis | Outlook]

My contribution:

Participated as the Software Excellence and Sutra lead in the initial POC discussion.

Was identified as the recipient of source-data walkthroughs and access support.

Began establishing access to the required log sources.

Connected the requested use case to the existing XITE and Sutra platform foundation.

Status: POC initiated; data assembly and access work underway

Log-data access path established

Brown, Cynthia provided me with explicit access routes for:

Ultrasound log files;

the associated database;

training documents required after access is granted. [RE: AWS AI...k analysis | Outlook]

The source states that a Vertica client must be configured after log-file access is approved. The retrieved correspondence does not confirm approval or completed configuration during Week 15.

Status: Access instructions received; completion not evidenced

Benefit-risk POC positioned as an XITE extension

The Extension of XITE V&V Program : New POC Quantitative Benefit–Risk Analysis positioned the POC as a logical extension of the XITE V&V compliance work. [Extension...k Analysis | Outlook]

The proposed extension would connect:

clinical workflows and user context;

Windchill SRS, RMF, IFU, and DHF exports;

complaints;

Vertica logs;

medical literature;

standards;

FDA benefit-risk templates. [Extension...k Analysis | Outlook]

The write-up states that the current XITE foundation provides Golden Thread Traceability, impact analysis, gap analysis, and AI-assisted test-scenario generation. The POC would extend that foundation into benefit-risk decision support by connecting verification and validation evidence to the benefit-risk rationale. [Extension...k Analysis | Outlook]

The communication included a proposed effort-saving figure of around 25%, explicitly marked “to be confirmed.” This is therefore a hypothesis, not a measured outcome. [Extension...k Analysis | Outlook]

The write-up was sent to Kumar, Nataraj for possible Tiger Team consideration. [Extension...k Analysis | Outlook]

Status: Business case framed; Tiger Team consideration requested

Joint requirements and traceability roadmap launched

In Bringing together our IEN AI initiatives on requirements and end-to-end traceability, Wartena, Frank asked Eldracher, Erik and me to lead stakeholder alignment. [RE: Bringi...aceability | Outlook]

The requested roadmap should explicitly address:

Key problems where AI can help.

Workflows in which the problems occur.

Solutions that need to be integrated into target-user workflows.

Internal and external guidelines and best practices.

Buy-versus-make options. [RE: Bringi...aceability | Outlook]

The requested output is an overview and recommendation for a consolidated roadmap, including how teams across IEN and Patient Safety and Quality should collaborate. [RE: Bringi...aceability | Outlook]

Eldracher, Erik confirmed that the two of us would align and bring the stakeholders together. [RE: Bringi...aceability | Outlook]

A one-hour Bringing together our IEN AI initiatives on requirements and end-to-end traceability was held on April 9 between Eldracher, Erik and me. The result contains no transcript or recap, so no meeting decisions beyond the email-confirmed leadership assignment are inferred. [Bringing t...aceability | Meeting]

Status: Co-leadership assigned; stakeholder alignment initiated

NOVA requirements-assistance evaluation

Singh, Rajender notified me that NOVA was available for exploration while being onboarded to the ITaaP IT platform. I was added to the user group. [NOVA for R...e- AI tool | Outlook]

The documented requirements workflow is:

select an initial requirement statement in Microsoft Word;

use the selected text as input;

choose Product Requirement;

optionally modify examples and structure;

run the analysis;

review issues against INCOSE writing rules;

review a suggested improved statement;

review similarity with requirements in the same document. [NOVA for R...e- AI tool | Outlook]

The source states that feedback on the tool would be requested around April 20. [NOVA for R...e- AI tool | Outlook]

This adds a concrete buy-versus-make input to the newly commissioned requirements and traceability roadmap, although that comparison is my recommended use of the evidence rather than a decision recorded in the source.

Status: Evaluation access provided

IGT-D POC scope aligned

The Alignment on the data and expectations was scheduled for April 9 to agree the data scope and assumptions for IGT-D. [Alignment...pectations | Meeting]

The documented POC assumptions were:

only IntraSight product documents would be ingested;

the initial data set would include URS, PRS, ERS, and test cases;

traceability would cover URS to PRS, PRS to ERS, PRS to test cases, and ERS to test cases;

the supplied documents might contain traceability gaps;

validation and remediation of identified gaps would occur after the POC. [Alignment...pectations | Meeting]

The meeting was intentionally scheduled to include me because I was working from the United States. [Alignment...pectations | Meeting]

Although the related meeting result contains an April 16 follow-up, that later activity falls outside Week 15 and is not reported as a Week 15 outcome.

Status: Initial data scope and traceability assumptions documented

XITE closeout slides submitted

The XITE closeout session requested concise project presentations covering:

the challenge;

the solution;

the impact or learning. [Re: XITE C...ut session | Outlook]

I submitted our project-closing slides on April 9. Stuijt, Tes confirmed that the slides were added to the final presentation. [Re: XITE C...ut session | Outlook]

A file result for 20260408-XITE-Cohort-4-Sutra-AI-Powered-V&V-Compliance-Closing-Slides.pptx contains project claims concerning traceability accuracy, impact-assessment effort, and requirements-to-test coverage. However, the file was last modified after Week 15, and the retrieved snippet does not show the supporting measurement method. I therefore do not present those percentages as validated Week 15 outcomes. [20260408-X...ing-Slides | PowerPoint]

Status: Closing slides accepted into the cohort presentation

April 20 Innovation Impact Week deep dive

The Important info for your deep dive session confirmed me as a Deep Dive presenter and supplied operational expectations for the session. [Re: Import...ve session | Outlook]

The documented requirements include:

verify recording rights;

understand the green-room setup;

confirm that recording has started;

track the maximum participant count if possible;

use an approved Teams background;

present from a quiet room;

include the supplied feedback slide;

allow approximately 15 minutes for questions;

keep the story relevant and simple for a broad audience. [Re: Import...ve session | Outlook]

Ruijter, Michiel de was assigned as the Communications point of contact for my session. [Re: Import...ve session | Outlook]

The same communication stated that more than 1,200 colleagues had registered for one or more Innovation Impact Week sessions. This is a program-wide registration figure, not the expected attendance for my specific session. [Re: Import...ve session | Outlook]

Status: Presenter support and operational requirements established

April 23 Inside XITE deep dive

Adebiyi, Omonigho introduced Wirjosemito, Jennifer as the Research contact leading preparation for the April 23 Inside XITE deep dive. [RE: Prepar...deep Dive | Outlook]

The planned format is hybrid, with a Bengaluru conference room and virtual participation. The correspondence states that 22 local colleagues were registered and that the proposed room was intended to accommodate 15 to 20 participants. [RE: Prepar...deep Dive | Outlook]

Mahesh, Caroline reserved 12F-MR11 – Airborne for the session. IT confirmed that the room has:

a Microsoft Teams Room setup;

two screens;

a fixed camera with auto-framing;

microphones on the table. [RE: Prepar...deep Dive | Outlook]

Wirjosemito, Jennifer created and shared I&D IIW - Inside XITE AI Powered E2E traceability.pptx for collaborative editing. [Wirjosemit...a message | Outlook], [Wirjosemit..." with you | Outlook]

The milestone deck XITE_V&V Compliance_Milestone 4 _ 30th March26.pptx was also shared with Wirjosemito, Jennifer. [XITE_V&V C...iance_Deck | Outlook]

Status: Room, AV configuration, Communications coordination, and shared deck established

External sharing guidance requested

Adebiyi, Omonigho connected me with Kleef, Ciska van after an IGT-S contact introduced a third-party TNO participant working on a PPP initiative with a similar use case. [RE: Questi...PPP vendor | Outlook]

The concern was whether XITE project outputs could be shared when PPP deliverables might subsequently be shared with organizations beyond Philips. [RE: Questi...PPP vendor | Outlook]

I requested a short discussion to provide the context and receive guidance. Kleef, Ciska van scheduled a meeting to discuss the question. The retrieved source does not contain the resulting guidance or an authorization to share.

Status: Guidance requested; no sharing decision evidenced

AIOrchestration access remained open

The RE: Implement POC Sutra - Traceability Platform for AIOrchestration as a pilot records continued follow-up for the AWS HSP account and access to S3, Lambda, ECR, and Neptune. [RE: Implem...as a pilot | Outlook]

The team requested an update on the account required for document ingestion. The retrieved result does not confirm that the requested services were enabled during Week 15.

Status: Access follow-up continued; completion not confirmed

Recruiting and Software Excellence enablement

I accepted a proposed second-round interview slot for a Senior Software DevOps Engineer candidate. The other required interviewer, Guymer, Scott, reported that the proposed time did not work because of travel and schedule constraints. The result does not contain a confirmed replacement time. [Re: 2nd Ro...24; 554023 | Outlook]

I was also mentioned in 1.- DevOps CG60 IN - Scrum master and Premium Custom Runners adoption.loop. The retrieved notice contains only the file title and does not provide the requested action or content, so no further contribution is inferred. [Mentioned...tion.loop" | Outlook]

Status: Interview participation accepted; final scheduling unresolved

3. Deliverables and Decisions

Deliverable or decision

My role

Status

Evidence

Ultrasound quantitative benefit-risk POC

Sutra and technical lead

Initiated

[RE: AWS AI...k analysis | Outlook], [AWS AI POC...s example) | Meeting]

Ultrasound log-access path

Access recipient

Instructions received

[RE: AWS AI...k analysis | Outlook]

Benefit-risk POC Tiger Team write-up

Technical contributor and platform lead

Submitted for consideration

[Extension...k Analysis | Outlook]

Joint IEN requirements and traceability roadmap

Co-lead with Eldracher, Erik

Assigned and initiated

[RE: Bringi...aceability | Outlook], [Bringing t...aceability | Meeting]

NOVA requirements-assistance evaluation

Evaluator

Access provided

[NOVA for R...e- AI tool | Outlook]

IGT-D Sutra POC

Platform lead

Scope documented

[Alignment...pectations | Meeting]

XITE Cohort closeout slides

Project presenter

Submitted and accepted

[Re: XITE C...ut session | Outlook]

April 20 Innovation Impact Week deep dive

Presenter

Communications support assigned

[Re: Import...ve session | Outlook]

April 23 Inside XITE deep dive

Co-host and technical presenter

Room, AV, and shared deck established

[RE: Prepar...deep Dive | Outlook], [Wirjosemit...a message | Outlook], [Wirjosemit..." with you | Outlook]

PPP external-sharing question

Project-output owner seeking guidance

Decision pending

[RE: Questi...PPP vendor | Outlook]

AIOrchestration pilot

Sutra contributor

AWS access still open

[RE: Implem...as a pilot | Outlook]

4. Risks, Blockers, and Support Needed

Risk or blocker

Evidence-based implication

Required action

Benefit-risk data is distributed across several systems

The POC depends on Windchill exports, complaints, Vertica logs, literature, standards, and FDA templates. [RE: AWS AI...k analysis | Outlook], [Extension...k Analysis | Outlook]

Create the agreed shared data location and record owners for each source.

Vertica access was not yet confirmed

Instructions were provided, but successful approval and configuration were not shown. [RE: AWS AI...k analysis | Outlook]

Complete access and confirm the approved data scope before ingestion.

Benefit claims remain hypotheses

The approximately 25% effort-saving statement was explicitly marked for confirmation. [Extension...k Analysis | Outlook]

Define a baseline and measurement method before using the figure as an outcome.

The cross-IEN roadmap spans multiple initiatives and organizations

The roadmap must cover workflows, guidelines, buy-versus-make choices, and collaboration across several functions. [RE: Bringi...aceability | Outlook]

Establish a common inventory and decision criteria before selecting a consolidated direction.

IGT-D remediation is outside the initial POC

Validation and remediation were explicitly deferred until after the POC. [Alignment...pectations | Meeting]

Ensure stakeholders distinguish POC traceability findings from completed remediation.

External sharing remains unresolved

Project outputs may flow into PPP deliverables accessible beyond Philips. [RE: Questi...PPP vendor | Outlook]

Obtain documented guidance before sharing project content.

AIOrchestration access was still incomplete

AWS HSP and dependent services remained under follow-up. [RE: Implem...as a pilot | Outlook]

Close the access decision or select a formally approved alternative environment.

Innovation Impact Week has significant operational dependencies

Recording rights, green-room readiness, AV, Communications support, Q&A, and feedback collection were explicitly required. [RE: Prepar...deep Dive | Outlook], [Re: Import...ve session | Outlook]

Complete a dry run and verify all presenter and room dependencies.

Existing recordings were deleted by expiration

Two Teams recordings were reported as deleted and temporarily restorable from the recycle bin. [Your Teams...ow deleted | Outlook], [Your Teams...ow deleted | Outlook]

Restore any recording required as durable evidence before the recovery period expires.

XITE time-writing closes shortly

The project was stated to close for time writing on April 17, with 60 planned April hours assigned to me. [XITE  V&V...me writing | Outlook]

Complete transition work and accurate time recording before the stated closure.

5. Commitments and Follow-Through

Completed during Week 15

Initiated the Ultrasound benefit-risk POC and identified the required evidence sources. [RE: AWS AI...k analysis | Outlook], [AWS AI POC...s example) | Meeting]

Obtained instructions for requesting Ultrasound log and database access. [RE: AWS AI...k analysis | Outlook]

Framed the benefit-risk POC as an extension for Tiger Team consideration. [Extension...k Analysis | Outlook]

Accepted co-leadership of the consolidated requirements and traceability roadmap. [RE: Bringi...aceability | Outlook]

Received NOVA evaluation access. [NOVA for R...e- AI tool | Outlook]

Documented the initial IGT-D data and traceability scope. [Alignment...pectations | Meeting]

Submitted the XITE closeout slides and received acceptance into the final presentation. [Re: XITE C...ut session | Outlook]

Established Communications and logistics support for the April 20 and April 23 sessions. [RE: Prepar...deep Dive | Outlook], [Re: Import...ve session | Outlook], [Wirjosemit..." with you | Outlook]

Initiated the formal guidance process for external sharing. [RE: Questi...PPP vendor | Outlook]

Open

Obtain and validate all benefit-risk POC source data. [RE: AWS AI...k analysis | Outlook]

Complete Ultrasound log and Vertica database access. [RE: AWS AI...k analysis | Outlook]

Define the benefit-risk POC baseline, success measures, and expert-review criteria. [Extension...k Analysis | Outlook]

Convene roadmap stakeholders and produce the requested consolidated recommendation. [RE: Bringi...aceability | Outlook]

Evaluate NOVA and record its relevance to the buy-versus-make decision. [NOVA for R...e- AI tool | Outlook]

Resolve the AIOrchestration AWS access route. [RE: Implem...as a pilot | Outlook]

Obtain formal guidance before sharing XITE outputs externally. [RE: Questi...PPP vendor | Outlook]

Complete presentation content and dry runs for both Innovation Impact Week sessions. [RE: Prepar...deep Dive | Outlook], [Re: Import...ve session | Outlook], [Wirjosemit..." with you | Outlook]

Restore any expired meeting recordings that remain necessary as project evidence. [Your Teams...ow deleted | Outlook], [Your Teams...ow deleted | Outlook]

6. Priorities for Week 16

Build the initial inventory of requirements and traceability initiatives for the cross-IEN roadmap. [RE: Bringi...aceability | Outlook]

Establish common evaluation criteria covering workflow fit, guidelines, buy-versus-make, governance, and integration needs. [RE: Bringi...aceability | Outlook], [NOVA for R...e- AI tool | Outlook]

Complete source-data ownership, access, and shared-space setup for the benefit-risk POC. [RE: AWS AI...k analysis | Outlook]

Define measurable POC outcomes without treating the provisional 25% effort-saving figure as validated. [Extension...k Analysis | Outlook]

Continue the bounded IGT-D ingestion and traceability POC under the documented assumptions. [Alignment...pectations | Meeting]

Finalize the April 20 deep-dive content, recording setup, Q&A allocation, and feedback slide. [Re: Import...ve session | Outlook]

Populate and rehearse the April 23 Inside XITE presentation using the shared deck and confirmed hybrid-room setup. [RE: Prepar...deep Dive | Outlook], [Wirjosemit..." with you | Outlook]

Secure a documented external-sharing decision for the PPP request. [RE: Questi...PPP vendor | Outlook]

Close any XITE time-writing and evidence-retention obligations before the stated project deadlines. [Your Teams...ow deleted | Outlook], [Your Teams...ow deleted | Outlook], [XITE  V&V...me writing | Outlook]

7. Meeting Coverage and Evidence Limitations

The meeting search returned 7 meetings for Week 15:

Meeting

Organizer

Scheduled time

Evidence available

AWS AI POC for Benefit risk analysis (Use X5-1C Xducer Noise as example)

Karuppan Chetty, Anuradha

April 6, 12:00 PM to 12:30 PM

Not identified as transcribed in the search result. Detailed follow-up was available from RE: AWS AI POC for Benefit risk analysis. [RE: AWS AI...k analysis | Outlook], [AWS AI POC...s example) | Meeting]

Demo Sutra

Kitsanelis, Christos

April 7, 9:00 AM to 10:00 AM

No transcript or meeting recap returned, so no outcomes are inferred. [Demo Sutra | Meeting]

IEN DoraMetrics Architecture and Code Overview

Gargi, Kumari

April 7, 11:30 AM to 12:00 PM

No transcript or meeting recap returned, so no outcomes are inferred. [IEN DoraMe...e Overview | Meeting]

PQR Technical Lead Collaboration Meeting

Ampan- Stonner, Nok

April 9, 9:00 AM to 9:25 AM

Recurring event. No transcript or recap returned. The calendar states that I tentatively accepted. [PQR Techni...on Meeting | Meeting]

Alignment on the data and expectations

Devadoss, Mohanraj

April 9, 12:00 PM to 12:25 PM

Not identified as transcribed. The invitation contains the explicit POC assumptions used in this report. [Alignment...pectations | Meeting]

Bringing together our IEN AI initiatives on requirements and end-to-end traceability

Eldracher, Erik

April 9, 1:00 PM to 2:00 PM

No transcript or recap returned. The related email confirms the co-leadership assignment. [RE: Bringi...aceability | Outlook], [Bringing t...aceability | Meeting]

[Data & AI CoP] BriefMD: An AI-powered feature that gives caregivers a single, comprehensive, centralized view of a patient’s medical history

Global Philips Data and AI Community of Practice

April 7, 9:00 AM to 10:00 AM

No transcript or recap returned. The calendar states that I had not RSVP'd, so no attendance or contribution is assumed. [[Data & AI...al history | Meeting]

No shared-screen images or shared-screen relevance hints were returned for these meetings.

Overall confidence

High for the benefit-risk POC scope, cross-IEN roadmap assignment, NOVA evaluation access, IGT-D POC assumptions, XITE closing-slide submission, Innovation Impact Week preparation, external-sharing concern, and AIOrchestration access status.

Medium for meeting participation where the search results provided only calendar metadata and no transcript, attendance evidence, or recap.

Manager-Ready Version

Subject: Weekly Impact Report | Week 15 | April 5-11, 2026

Hi Nataraj,

Here is my Week 15 update.

Key outcomes

We initiated an Ultrasound benefit-risk analysis POC using the existing XITE and Sutra foundation. The proposed data set includes Windchill design and risk artifacts, complaints, Vertica logs, medical literature, standards, and an FDA benefit-risk template. The intended output is an AI-assisted draft with expert review. [RE: AWS AI...k analysis | Outlook], [AWS AI POC...s example) | Meeting]

Sundar positioned this initiative as a logical extension of the completed XITE V&V work and submitted the write-up for Tiger Team consideration. The approximately 25% effort-saving figure in the write-up remains to be confirmed. [Extension...k Analysis | Outlook]

I received the request paths for Ultrasound log access, database access, and Vertica training material. Successful approval and configuration were not yet evidenced. [RE: AWS AI...k analysis | Outlook]

Frank asked Erik and me to co-lead a consolidated roadmap across IEN and Patient Safety and Quality for AI-assisted requirements and end-to-end traceability. The roadmap must address problems, workflows, guidelines, buy-versus-make choices, and a joint execution model. [RE: Bringi...aceability | Outlook]

I received access to evaluate NOVA, an AI requirements-assistance tool that checks selected requirements against INCOSE rules, suggests improvements, and identifies similar requirements. [NOVA for R...e- AI tool | Outlook]

We documented the initial IGT-D Sutra POC scope around IntraSight URS, PRS, ERS, and test cases, with four defined traceability paths. Validation and remediation remain outside the initial POC. [Alignment...pectations | Meeting]

I submitted our XITE Cohort closing slides, and the program manager confirmed that they were added to the closeout presentation. [Re: XITE C...ut session | Outlook]

Communications and logistics support are now in place for my April 20 deep dive and the April 23 Inside XITE session. The April 23 hybrid room has two screens, a Teams Room setup, a fixed auto-framing camera, and table microphones. [RE: Prepar...deep Dive | Outlook], [Re: Import...ve session | Outlook]

I initiated a formal discussion about what XITE outputs may be shared with a third-party PPP participant when the downstream deliverables may be available beyond Philips. No sharing decision is yet recorded. [RE: Questi...PPP vendor | Outlook]

The AIOrchestration pilot still required confirmation of the AWS HSP account and supporting service access for document ingestion. [RE: Implem...as a pilot | Outlook]

Risks and support needed

The benefit-risk POC depends on timely access to several regulated and distributed data sources.

Benefit statements must remain hypotheses until baseline measurements are available.

The joint roadmap needs clear scope and decision criteria to avoid duplicating existing requirements tools.

IGT-D remediation is explicitly outside the initial POC.

External sharing must not proceed until formal guidance is received.

Innovation Impact Week requires final content alignment, dry runs, recording verification, and hybrid-room readiness.

Two prior meeting recordings expired and may need restoration if required as durable evidence. [Your Teams...ow deleted | Outlook], [Your Teams...ow deleted | Outlook]

Priorities for Week 16

Convene the requirements and traceability roadmap stakeholders.

Inventory current tools and initiatives, including NOVA, Kairos ReqSpec, and Sutra.

Complete benefit-risk POC data access and ownership.

Define the POC baseline and measurable success criteria.

Continue the bounded IGT-D ingestion work.

Finalize and rehearse the April 20 and April 23 sessions.

Obtain formal external-sharing guidance.

Complete XITE transition, time-writing, and evidence-retention obligations.

Regards,Datta